Evidence map›Paper›PMID 8061604›Full record

ArticleProtein science : a publication of the Protein Society1994

Contribution of a single heavy chain residue to specificity of an anti-digoxin monoclonal antibody.

J F Schildbach, S Y Shaw, R E Bruccoleri, E Haber, L A Herzenberg, G C Jager, P D Jeffrey, D J Panka, D R Parks, R I Near

Open access · bronzeAbstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 1994. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. In vitro scanning saturation mutagenesis of an antibody binding pocket.Proceedings of the National Academy of Sciences of the United States of America · 1997
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

J F SchildbachProgram on Immunology, Harvard University Graduate School of Arts and Sciences, Cambridge, Massachusetts 02138.
S Y Shaw
R E Bruccoleri
E Haber
L A Herzenberg
G C Jager
P D Jeffrey
D J Panka
D R Parks
R I Near
Harvard University · USMassachusetts General Hospital · USBristol-Myers Squibb (United States) · USStanford University · US

Funding

STRUCTURE AND DIVERSITY OF DIGOXIN-SPECIFIC HYBRIDOMA PROTEINSP01HL019259 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI MARGOLIES, MICHAEL N · 1985 to 1990
–
ENGINEERING OF ANTIDIGOXIN ANTIBODY COMBINING SITESR01HL047415 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI MARGOLIES, MICHAEL N · 1992 to 1999
–
NHLBI NIH HHS P01 HL19259NHLBI NIH HHS R01 HL47415
6 · The paper itself

Abstract

Two distinct spontaneous variants of the murine anti-digoxin hybridoma 26-10 were isolated by fluorescence-activated cell sorting for reduced affinity of surface antibody for antigen. Nucleotide and partial amino acid sequencing of the variant antibody variable regions revealed that 1 variant had a single amino acid substitution: Lys for Asn at heavy chain position 35. The second variant antibody had 2 heavy chain substitutions: Tyr for Asn at position 35, and Met for Arg at position 38. Mutagenesis experiments confirmed that the position 35 substitutions were solely responsible for the markedly reduced affinity of both variant antibodies. Several mutants with more conservative position 35 substitutions were engineered to ascertain the contribution of Asn 35 to the binding of digoxin to antibody 26-10. Replacement of Asn with Gln reduced affinity for digoxin 10-fold relative to the wild-type antibody, but maintained wild-type fine specificity for cardiac glycoside analogues. All other substitutions (Val, Thr, Leu, Ala, and Asp) reduced affinity by at least 90-fold and caused distinct shifts in fine specificity. The Ala mutant demonstrated greatly increased relative affinities for 16-acetylated haptens and haptens with a saturated lactone. The X-ray crystal structure of the 26-10 Fab in complex with digoxin (Jeffrey PD et al., 1993, Proc Natl Acad Sci USA 90:10310-10314) reveals that the position 35 Asn contacts hapten and forms hydrogen bonds with 2 other contact residues. The reductions in affinity of the position 35 mutants for digoxin are greater than expected based upon the small hapten contact area provided by the wild-type Asn. We therefore performed molecular modeling experiments which suggested that substitution of Gln or Asp can maintain these hydrogen bonds whereas the other substituted side chains cannot. The altered binding of the Asp mutant may be due to the introduction of a negative charge. The similarities in binding of the wild-type and Gln-mutant antibodies, however, suggest that these hydrogen bonds are important for maintaining the architecture of the binding site and therefore the affinity and specificity of this antibody. The Ala mutant eliminates the wild-type hydrogen bonding, and molecular modeling suggests that the reduced side-chain volume also provides space that can accommodate a congener with a 16-acetyl group or saturated lactone, accounting for the altered fine specificity of this antibody.

Indexed as

Amino Acid SequenceAnimalsAntibodies, MonoclonalAntibody SpecificityBase SequenceBinding SitesCardenolidesCardiac GlycosidesCrystallography, X-RayDigoxinDNAGenetic VariationHybridomasImmunoglobulin Heavy ChainsMiceModels, MolecularAntibodies, MonoclonalCardenolidesCardiac GlycosidesDigoxinDNAImmunoglobulin Heavy Chainsoleandrin

Identifiers

PMID8061604
PMCPMC2142714
OpenAlexW2136188860

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.